News & Updates

Apathy may have a significant impact on cognitive health of stroke survivors, according to results of a cross-sectional study by the Chinese University of Hong Kong.

An intranasally administered recombinant human erythropoietin without erythropoietic activity and shorter plasma half-life (neuroEPO) restores cognitive function or delays progression in most patients with mild-to-moderate Alzheimer’s disease, results of the phase II/III double-blind, placebo-controlled ATHENEA trial have shown.

It is extremely important to safeguard children’s mental health in the digital age. Recognizing the signs of online and gaming addiction early and providing early assistance as well as a supportive environment are vital for children to become mentally resilient adults, says Dr Tee Bee Chin.

Adding subcutaneous daratumumab to the three-drug regimen containing bortezomib, lenalidomide, and dexamethasone (VRd) appears to improve outcomes for transplant-eligible patients with newly diagnosed multiple myeloma (MM), with extended disease-free periods and increased depth of response, according to the phase III PERSEUS trial.